Immune cell timing may hold key to better stroke recovery
NCT ID NCT02900833
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study looks at how certain immune cells (neutrophils) behave in people having a severe stroke. Researchers want to find the best time and target for treatments that block these cells. 440 adults having emergency stroke treatment will give blood samples and have their recovery tracked. The goal is to learn, not to test a new drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondation Ophtalmologique Adolphe de Rothschild
Paris, 75019, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can a drug boost brain recovery after stroke?
- Can a blood Clot's inflammation predict stroke recovery?
- Can a new infusion drug boost stroke recovery?
- A Pocket-Sized MRI for strokes? new device put to the test
- Can removing clots from tiny brain arteries boost stroke recovery?